Jonathan Allan - 18 Aug 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: GENERAL COUNSEL & CORP SEC
Signature: /s/ Jonathan Allan
Issuer symbol: STOK
Transactions as of: 18 Aug 2025
Transactions value $: -$30,695
Form type: 4
Filing time: 20 Aug 2025, 16:11:05 UTC
Previous filing: 18 Aug 2025
Next filing: 03 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Allan Jonathan	GENERAL COUNSEL & CORP SEC	C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD	/s/ Jonathan Allan	20 Aug 2025	0001966716

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Sale	-$30.7K	-1.68K	-6.57%	$18.24	23.9K	18 Aug 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50 per share, inclusive.